These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17223695

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
    Athanassiou Z, Dias RL, Moehle K, Dobson N, Varani G, Robinson JA.
    J Am Chem Soc; 2004 Jun 09; 126(22):6906-13. PubMed ID: 15174860
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tethering of proteins to RNAs using the bovine immunodeficiency virus-Tat peptide and BIV-TAR RNA.
    Wakiyama M, Kaitsu Y, Muramatsu R, Takimoto K, Yokoyama S.
    Anal Biochem; 2012 Aug 15; 427(2):130-2. PubMed ID: 22617800
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thermodynamics and solvation dynamics of BIV TAR RNA-Tat peptide interaction.
    Goel T, Kumar S, Maiti S.
    Mol Biosyst; 2013 Jan 27; 9(1):88-98. PubMed ID: 23114563
    [Abstract] [Full Text] [Related]

  • 11. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F, Brondani V, Flörsheimer A, Stark W, Blommers MJ, Klimkait T.
    Biochemistry; 1998 Apr 14; 37(15):5086-95. PubMed ID: 9548739
    [Abstract] [Full Text] [Related]

  • 12. A comparative binding study of BIV Tat peptide against its TAR RNA duplex, RNA-DNA heteroduplex and DNA duplex.
    Tok JB, Bi L.
    Bioorg Med Chem Lett; 2005 Jan 03; 15(1):129-33. PubMed ID: 15582425
    [Abstract] [Full Text] [Related]

  • 13. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B, Wainberg MA, Frankel AD.
    J Virol; 2003 Feb 03; 77(3):1984-91. PubMed ID: 12525632
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structural model of the HIV-1 Tat(46-58)-TAR complex.
    Seewald MJ, Metzger AU, Willbold D, Rösch P, Sticht H.
    J Biomol Struct Dyn; 1998 Dec 03; 16(3):683-92. PubMed ID: 10052624
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex.
    Ye X, Kumar RA, Patel DJ.
    Chem Biol; 1995 Dec 03; 2(12):827-40. PubMed ID: 8807816
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
    Lu J, Nguyen L, Zhao L, Xia T, Qi X.
    Biochemistry; 2015 Jun 16; 54(23):3687-93. PubMed ID: 26016940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.